CME Group 過去の業績
過去 基準チェック /46
CME Groupは、平均年間12%の収益成長を遂げていますが、 Capital Markets業界の収益は、年間 成長しています。収益は、平均年間7% 8.7%収益成長率で 成長しています。 CME Groupの自己資本利益率は16.2%であり、純利益率は63.1%です。
主要情報
11.98%
収益成長率
11.89%
EPS成長率
| Capital Markets 業界の成長 | 10.26% |
| 収益成長率 | 8.70% |
| 株主資本利益率 | 16.16% |
| ネット・マージン | 63.12% |
| 次回の業績アップデート | 21 Oct 2026 |
最近の業績更新
Recent updates
Seeking Alpha • Aug 25
CME Group: The Price Stands Still, But The Growth Engines Accelerate
Summary CME Group remains a Buy, driven by robust volumes, an expanding fixed-income ecosystem, and product innovation, despite a full valuation. CME's Q2 2026 saw record revenues, strong margins near 70%, and notable growth in international and retail trading volumes. Key catalysts include Treasury Link integration, 24/7 trading, Compute futures, and regulatory tailwinds in clearing requirements. Competition from perpetual futures and a premium valuation at 21x forward earnings temper near-term upside, but long-term growth and capital returns support the rating. Read the full article on Seeking Alpha
ナラティブ更新 • Jul 28
CME: Perpetual Futures Dispute And New Contracts Will Shape Earnings Profile
The analyst fair value estimate for CME Group has been trimmed by about $6.64 to $282.36, as analysts balance slightly higher projected revenue growth with lower profit margin assumptions and a modestly reduced future P/E multiple following a mix of recent target cuts and increases across the Street. Analyst Commentary Recent research on CME Group shows a split view, with some firms lifting price targets and ratings while others trim expectations and flag competitive threats.ナラティブ更新 • Jul 09
CME: Crypto Perpetual Futures Dispute Will Reshape Long Term Earnings Power
The analyst price target for CME Group has been trimmed by about $14 to reflect slightly softer revenue growth assumptions, a modestly higher discount rate, and lower future P/E multiples that many analysts link to competitive concerns around perpetual futures, despite broadly constructive views on the core franchise. Analyst Commentary Recent research on CME Group highlights a split view, with some analysts seeing attractive upside after the share pullback and others focusing on competitive threats and pricing pressure.ナラティブ更新 • Jun 24
CME: Crypto Perpetual Futures Dispute Will Shape Future Earnings Power
The analyst price target for CME Group has shifted slightly lower, with fair value moving from about $306.47 to $302.60 as analysts weigh ongoing concerns around perpetual futures and potential multiple compression against views that recent share weakness and structural demand drivers still support an attractive long term setup. Analyst Commentary Recent research on CME Group shows a split between bullish analysts who see the recent pullback and product portfolio as supportive for long term value, and more cautious voices focused on competitive threats from perpetual futures and the potential impact on valuation multiples.分析記事 • Jun 18
CME Group (CME) Stock Could Be 18% Undervalued After CEO Succession News
CME Group (CME) stock is in focus after the company confirmed a leadership transition that will see long time Chairman and CEO Terry Duffy move to Executive Chairman while President and CFO Lynne Fitzpatrick becomes CEO in 2027. See our latest analysis for CME Group. The leadership announcement landed against a weaker backdrop for CME Group stock, with the share price down 3.46% over the past day and 17.23% over the past 30 days, while the 5 year total shareholder return of 45.07% still...ナラティブ更新 • Jun 05
CME: Crypto And AI Futures Expansion Will Shape Future Earnings Power
Analysts have trimmed their average price target for CME Group to about $306.47. This reflects concerns that revenue momentum could soften as geopolitical volatility eases and that fresh competition in bitcoin perpetual futures may weigh on exchange valuations, even as several firms still see the competitive risk as manageable.ナラティブ更新 • May 15
CME: Mixed Street Views And New Markets Will Shape Future Earnings Power
Narrative Update on CME Group The analyst price target for CME Group has been trimmed by about $2, reflecting updated views on slightly softer revenue growth and a modestly lower future P/E multiple. At the same time, some analysts highlight areas of support such as commodities volumes as well as agriculture and prediction markets.ナラティブ更新 • Apr 27
CME: Volatile Street Views And New Futures Will Shape Trading Mix
Analysts have nudged their fair value estimate for CME Group down to $308.20 from $311.67, reflecting slightly softer revenue growth assumptions and a higher discount rate, partly balanced by a higher projected profit margin and a modestly lower future P/E, in line with the mix of recent price target trims and increases across the Street. Analyst Commentary Recent Street research on CME Group has been active on both sides, with several firms adjusting price targets and ratings in different directions.ナラティブ更新 • Apr 11
CME: Volatility And New Contracts Will Shape Rare Earths And Crypto Volumes
The updated analyst price target for CME Group has moved higher by about $5 to $311.67. This change reflects analysts' use of a slightly lower discount rate, a modestly higher assumed revenue growth rate, and a marginally higher future P/E multiple, even as they factor in a small trim to projected profit margins.ナラティブ更新 • Mar 26
CME: Volatility And New Contracts Will Shape Rare Earths And Volume Mix
Analysts have made a modest upward adjustment to the CME Group fair value estimate to about $307 from roughly $305, reflecting slightly revised assumptions for discount rate, revenue growth, profit margin, and future P/E following a mix of recent rating changes and price target tweaks across the Street. Analyst Commentary Recent research on CME Group reflects a mixed but generally balanced backdrop, with several firms adjusting ratings and price targets in different directions.ナラティブ更新 • Mar 11
CME: Volatility And New Contracts Will Shape Rare Earths And Clearing Outlook
Our analyst price target for CME Group has moved modestly higher to $305.21 from $299.29, as analysts factor in slightly stronger modeled revenue growth and profitability. This is partially offset by a more conservative future P/E assumption and mixed views on volume drivers across product lines.ナラティブ更新 • Feb 25
CME: Volatility And New Contracts Will Shape Futures And Clearing Outlook
The analyst price target for CME Group edges higher to $232, with recent updates reflecting analysts' focus on firmer commodities volumes, as well as a more expense conscious outlook in their refreshed earnings models. Analyst Commentary Recent Street research around CME Group reflects a mix of optimism on volumes and earnings power, alongside caution on valuation and the cost base.ナラティブ更新 • Feb 10
CME: Volatility And Prediction Markets Will Guide Futures And Clearing Expansion Outlook
The updated analyst price target for CME Group edges higher to about US$297 from roughly US$290, reflecting analysts' use of a slightly lower discount rate, a modestly higher assumed revenue growth rate, and a similar future P/E multiple despite a slightly lower profit margin input. Analyst Commentary Street research on CME Group in recent sessions centers on a cluster of revised price targets and at least one rating change, with several bullish analysts lifting their targets by varying dollar amounts and one major bank fine tuning its view in both directions over a short time frame.ナラティブ更新 • Jan 27
CME: Volatility And Prediction Markets Will Shape Futures Activity Outlook
The analyst price target for CME Group is now US$290.40, a move of about US$2 from the prior US$288.33, as analysts factor in slightly different assumptions for fair value, discount rate, revenue growth, profit margins, and future P/E following mixed recent research that includes both a modest target cut and an upgrade linked to a tilt toward volatility. Analyst Commentary Recent research on CME Group reflects a mix of optimism and caution, with one firm trimming its price target slightly and another upgrading the stock on what it sees as a better setup for volatility related trading activity.ナラティブ更新 • Jan 12
CME: Fee Moat And Prediction Markets Will Shape Futures Activity Outlook
Narrative Update: CME Group CME Group's fair value estimate has edged up by about $1 to roughly $288 per share, as analysts cite the company's strong futures and options moat, a higher price target range of up to $314, and interest in its role within prediction markets as key supports for the updated outlook. Analyst Commentary Recent Street research has been generally constructive on CME Group, with several bullish analysts adjusting their price targets higher and highlighting the company's futures and options franchise as a key support for valuation.ナラティブ更新 • Dec 27
CME: Fee Resilience And Prediction Markets Will Balance Lower Volatility Risks
Analysts have nudged their average price target on CME Group modestly higher, to approximately $287 from about $286, citing the company’s resilient fee-based revenue mix, strong competitive moat in futures and options, and supportive demand signals from prediction market partnerships despite some conflicting views on near term volume volatility. Analyst Commentary Recent Street research presents a mixed but generally constructive view on CME Group, with upward moves in price targets tempered by concerns around volume sensitivity and valuation risk if volatility normalizes.ナラティブ更新 • Dec 13
CME: Fee Resilience And New Prediction Markets Will Help Navigate Volatility
Analysts have raised their fair value estimate for CME Group by about $1 to roughly $286 per share, citing the company’s resilient clearing and transaction fee driven revenue base, modestly higher long term growth expectations, and a reinforced competitive moat highlighted in recent target revisions across the Street. Analyst Commentary Street research on CME Group reflects a wide range of views on valuation and execution, with recent target changes clustering around expectations for resilient fee income but diverging on the sustainability of growth and the impact of lower volatility.ナラティブ更新 • Nov 16
CME: Revenue Resilience And New Ventures Will Balance Volatility Risks Ahead
The average analyst price target for CME Group was raised by approximately $3 to $285, as analysts point to the firm's resilient revenue streams and strong market position amid continued macroeconomic uncertainty. Analyst Commentary Recent analyst activity reflects a mix of optimism and caution regarding CME Group's performance and outlook, particularly as the firm navigates shifting macroeconomic and market conditions.収支内訳
収支内訳
CME Group の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Jun 26 | 6,757 | 4,265 | 1,828 | 0 |
| 31 Mar 26 | 6,744 | 4,235 | 1,790 | 0 |
| 31 Dec 25 | 6,507 | 4,021 | 1,751 | 0 |
| 30 Sep 25 | 6,385 | 3,717 | 1,695 | 0 |
| 30 Jun 25 | 6,433 | 3,721 | 1,681 | 0 |
| 31 Mar 25 | 6,274 | 3,581 | 1,654 | 0 |
| 31 Dec 24 | 6,120 | 3,482 | 1,646 | 0 |
| 30 Sep 24 | 6,034 | 3,422 | 1,630 | 0 |
| 30 Jun 24 | 5,788 | 3,262 | 1,590 | 0 |
| 31 Mar 24 | 5,616 | 3,157 | 1,577 | 0 |
| 31 Dec 23 | 5,579 | 3,186 | 1,515 | 0 |
| 30 Sep 23 | 5,338 | 3,011 | 1,536 | 0 |
| 30 Jun 23 | 5,228 | 2,942 | 1,519 | 0 |
| 31 Mar 23 | 5,104 | 2,828 | 1,491 | 0 |
| 31 Dec 22 | 5,019 | 2,657 | 1,399 | 0 |
| 30 Sep 22 | 4,833 | 2,633 | 1,443 | 0 |
| 30 Jun 22 | 4,715 | 2,889 | 1,440 | 0 |
| 31 Mar 22 | 4,657 | 2,745 | 1,448 | 0 |
| 31 Dec 21 | 4,690 | 2,617 | 1,418 | 0 |
| 30 Sep 21 | 4,630 | 2,435 | 1,521 | 0 |
| 30 Jun 21 | 4,600 | 1,920 | 1,543 | 0 |
| 31 Mar 21 | 4,603 | 1,913 | 1,564 | 0 |
| 31 Dec 20 | 4,884 | 2,105 | 1,491 | 0 |
| 30 Sep 20 | 4,911 | 2,151 | 1,545 | 0 |
| 30 Jun 20 | 5,109 | 2,375 | 1,539 | 0 |
| 31 Mar 20 | 5,200 | 2,386 | 1,532 | 0 |
| 31 Dec 19 | 4,868 | 2,117 | 1,447 | 0 |
| 30 Sep 19 | 4,959 | 2,033 | 1,518 | 0 |
| 30 Jun 19 | 4,588 | 1,808 | 1,370 | 0 |
| 31 Mar 19 | 4,377 | 1,860 | 1,235 | 0 |
| 31 Dec 18 | 4,309 | 1,962 | 1,126 | 0 |
| 30 Sep 18 | 3,973 | 4,516 | 977 | 0 |
| 30 Jun 18 | 3,959 | 4,413 | 996 | 0 |
| 31 Mar 18 | 3,824 | 4,262 | 993 | 0 |
| 31 Dec 17 | 3,645 | 4,063 | 929 | 0 |
| 30 Sep 17 | 3,658 | 1,498 | 1,014 | 0 |
| 30 Jun 17 | 3,609 | 1,662 | 1,000 | 0 |
| 31 Mar 17 | 3,590 | 1,566 | 1,008 | 0 |
| 31 Dec 16 | 3,595 | 1,534 | 971 | 0 |
| 30 Sep 16 | 3,496 | 1,452 | 984 | 0 |
| 30 Jun 16 | 3,505 | 1,340 | 994 | 0 |
| 31 Mar 16 | 3,418 | 1,284 | 986 | 0 |
| 31 Dec 15 | 3,327 | 1,247 | 985 | 0 |
| 30 Sep 15 | 3,354 | 1,262 | 998 | 0 |
質の高い収益: CMEは 高品質の収益 を持っています。
利益率の向上: CMEの現在の純利益率 (63.1%)は、昨年(57.9%)よりも高くなっています。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: CMEの収益は過去 5 年間で年間12%増加しました。
成長の加速: CMEの過去 1 年間の収益成長率 ( 14.6% ) は、5 年間の平均 ( 年間12%を上回っています。
収益対業界: CMEの過去 1 年間の収益成長率 ( 14.6% ) Capital Markets業界32.9%を上回りませんでした。
株主資本利益率
高いROE: CMEの 自己資本利益率 ( 16.2% ) は 低い とみなされます。
総資産利益率
使用総資本利益率
過去の好業績企業の発掘
企業分析と財務データの現状
| データ | 最終更新日（UTC時間） |
|---|---|
| 企業分析 | 2026/09/11 04:20 |
| 終値 | 2026/09/11 00:00 |
| 収益 | 2026/06/30 |
| 年間収益 | 2025/12/31 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
このレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。
シンプリー・ウォールストリート分析モデルを設計・構築した ご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
CME Group Inc. 13 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。32
| アナリスト | 機関 |
|---|---|
| Stephen Biggar | Argus Research Company |
| Benjamin Budish | Barclays |
| Roger Freeman | Barclays |